SecBot SecBot
SC 13G ·Filed Oct 26, 2026
CT

CTY

CITY THERAPEUTICS, INC.
NEUTRAL
Impact 4/10
Processed21h 53m ago SEC0000905148-26-004557
Passive investor 5%+ stake

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000905148-26-004557
Document: 0000905148-26-004557-index-headers.html0000905148-26-004557
Document: 0000905148-26-004557-index.html0000905148-26-004557
Document: 0000905148-26-004557.txt0000905148-26-004557
18 reports for CTY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CTY — sortable, filterable
TypeNow
Oct 26, 2026
today
SC 13D
NEUTRAL ★ 5/10
$20.79awaiting T+1—$21.03 (+1.15%)
Oct 26, 2026
today
SC 13G
NEUTRAL ★ 4/10
$20.79awaiting T+1—$21.03 (+1.15%)
Oct 22, 2026
5d ago
SC 13G
NEUTRAL ★ 3/10
$20.77 $20.77· 0.00%▲ +0.52%$21.03 (+1.25%)
Oct 19, 2026
7d ago
Insider Cluster
BULLISH ★ 6/10
$20.83 $20.43▼ −1.92%▼ −2.45%$21.03 (+0.96%)
Oct 19, 2026
7d ago
Press Release
NEUTRAL ★ 5/10
$20.83 $20.43▼ −1.92%▼ −2.45%$21.03 (+0.96%)
Oct 16, 2026
10d ago
424B4
NEUTRAL ★ 5/10
$21.46 $20.83▼ −2.94%▼ −3.27%$21.03 (−2.00%)
Oct 16, 2026
11d ago
EFFECT
NEUTRAL ★ 5/10
$22.40 $21.46▼ −4.20%▼ −4.62%$21.03 (−6.12%)
Oct 15, 2026
11d ago
3
NEUTRAL ★ 3/10
$22.40 $21.46▼ −4.20%▼ −4.62%$21.03 (−6.12%)
Oct 15, 2026
11d ago
3
NEUTRAL ★ 2/10
$22.40 $21.46▼ −4.20%▼ −4.62%$21.03 (−6.12%)
Oct 15, 2026
11d ago
3
NEUTRAL ★ 2/10
$22.40 $21.46▼ −4.20%▼ −4.62%$21.03 (−6.12%)
Showing 10 of 18

US Market Status

Market Open — Closes in 1h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh CTY Intelligence

Analysis is for subscribers only.

Subscribe for Full Access